全文获取类型
收费全文 | 180750篇 |
免费 | 1362篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1235篇 |
儿科学 | 6882篇 |
妇产科学 | 3116篇 |
基础医学 | 17214篇 |
口腔科学 | 1680篇 |
临床医学 | 12735篇 |
内科学 | 31782篇 |
皮肤病学 | 796篇 |
神经病学 | 17029篇 |
特种医学 | 9405篇 |
外科学 | 29442篇 |
综合类 | 2399篇 |
一般理论 | 8篇 |
预防医学 | 18480篇 |
眼科学 | 2828篇 |
药学 | 9802篇 |
中国医学 | 624篇 |
肿瘤学 | 16665篇 |
出版年
2021年 | 81篇 |
2019年 | 80篇 |
2018年 | 22009篇 |
2017年 | 17418篇 |
2016年 | 19558篇 |
2015年 | 971篇 |
2014年 | 877篇 |
2013年 | 914篇 |
2012年 | 7126篇 |
2011年 | 21173篇 |
2010年 | 18887篇 |
2009年 | 11589篇 |
2008年 | 19658篇 |
2007年 | 21827篇 |
2006年 | 673篇 |
2005年 | 2298篇 |
2004年 | 3520篇 |
2003年 | 4490篇 |
2002年 | 2634篇 |
2001年 | 473篇 |
2000年 | 595篇 |
1999年 | 319篇 |
1998年 | 253篇 |
1997年 | 259篇 |
1996年 | 139篇 |
1995年 | 136篇 |
1994年 | 153篇 |
1993年 | 106篇 |
1992年 | 197篇 |
1991年 | 268篇 |
1990年 | 295篇 |
1989年 | 232篇 |
1988年 | 201篇 |
1987年 | 181篇 |
1986年 | 159篇 |
1985年 | 174篇 |
1984年 | 146篇 |
1983年 | 115篇 |
1982年 | 94篇 |
1981年 | 79篇 |
1980年 | 101篇 |
1979年 | 130篇 |
1978年 | 102篇 |
1976年 | 70篇 |
1975年 | 77篇 |
1974年 | 84篇 |
1973年 | 64篇 |
1972年 | 68篇 |
1970年 | 77篇 |
1969年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
D Siegel 《Journal of the American Optometric Association》1988,59(11):885-888
Examination of a 49-year-old black female with a history of sickle cell anemia revealed proliferative sickle cell retinopathy. A review of the pathophysiology of the systemic disease as it relates to the clinical diagnosis and treatment of the retinopathy is presented. 相似文献
102.
Catecholamine excess has been shown to produce 2 distinct forms of irreversible myocardial necrosis termed contraction band lesions. Calcium channel blocking agents provided a variable protective effect from these contraction band lesions. The purpose of this study was to determine the temporal responses of the most effective of these blocking agents, diltiazem, when given before, simultaneous with or after an initial exposure to a necrogenic infusion of norepinephrine (NE). Forty-one adult mongrel dogs were anesthetized with sodium pentobarbital (32 mg/kg) and infused with saline solution or NE (4 micrograms/kg/min) for 60 minutes or diltiazem at a rate of 20 micrograms/kg/min for the first 5 minutes and 10 micrograms/kg/min for the remaining 70 minutes. Diltiazem was infused as pretreatment 15 minutes before continued infusion with NE for 60 minutes, simultaneously infused with NE for 60 minutes or delayed 30 minutes after the start of NE infusion. Diltiazem alone exhibited no significant effect on hemodynamics, but pretreatment with diltiazem was able to moderate the rapid NE-induced increases in heart rate. NE infusion produced significant numbers of the 2 forms of contraction band lesions: (1) paradiscal contraction band lesions involving a small portion of the cell adjacent to the disc, and (2) holocytic contraction band lesions involving the entire cell. Diltiazem reduced the number of contraction band lesions, particularly the holocytic contraction band lesions, provided diltiazem was available before the insult and massive influx of calcium with a pharmacologic dose of NE. Although the exact mechanism of diltiazem's cardioprotective properties is not known, the timing of drug administration does appear to affect the degree of protection. 相似文献
103.
104.
105.
106.
G. Vacca E. Marano V. Brescia Morra R. Lanzillo M. De Vito E. Parente G. Orefice 《Neurological sciences》2007,28(3):133-135
The prevalence of primary headache (PH) in a multiple sclerosis (MS) sample vs. control healthy subjects was investigated at a neurological clinic in 2004–2005: 122 of 238 (51%) MS patients and 57 of
238 (23%) controls proved to be affected by headache. The groups did not differ for the rates of PH types. Headache types
of MS patients were comparable to those of PH patients that were observed at the same institute in a case-control comparison.
First symptoms of headache preceded those of MS in two thirds of cases. Headache features did not significantly change after
MS onset. Comorbidity of MS and PH could be explained by some common clinical and biological traits. 相似文献
107.
Volker Heinemann 《Breast cancer research and treatment》2003,81(1):43-48
Single-agent chemotherapy of metastatic breast cancer is the treatment of choice in patients with slow tumor progression and asymptomatic disease. In this patient group, the choice of drugs is based more on good tolerability than on efficacy. By contrast, symptomatic or rapidly progressing disease requires the use of highly active regimens where more weight is put on reliable antitumor activity. While anthraycline-based combination regimens have set the standard of effective treatment, the addition of docetaxel (and to a lesser extent paclitaxel) has improved tumor response, but failed to induce a consistent prolongation of survival. Based on retrospective analyses, it is hypothesised that the combined use of anthracyclines and taxanes in first-line therapy may be most beneficial in defined subgroups: after adjuvant chemotherapy, in patients with HER-2 gene amplification, possibly also in patients with rapidly progressing visceral disease. 相似文献
108.
109.
Ohne Zusammenfassung 相似文献
110.